Pay in 4 interest-free payments of $6.86 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
This study compared the safety and efficacy of four distinct osocimab dosages (0.3, 0.6, 1.2, and 1.8 mg/kg) to enoxaparin 40 mg once daily and apixaban 2.5 mg twice daily
Whether you are a researcher exploring new territory, a patient frustrated by partial relief, or a clinician curious about what your colleagues are seeing, every section that follows is built on what the science actually says right now, not what we hope it will say later
The patient did not receive any premedication before the desensitisation procedure
PMID: 28189172 20 A case report: subacute combined degeneration of the spinal cord and pernicious anemia caused by autoimmune gastritis
Functional adds deeper root-cause testing and quarterly optimization
US$ 24.57
US$ 23.22
US$ 28.27
US$ 26.97
US$ 25.17
